Document is current
Any future updates will be listed below
-
Authors
Henningsohn, Lars
Larsson, Henrik
Kuja-Halkola, Ralf
Cederlöf, Martin
-
Funding
Funding for this research was provided by:
Riksbankens Jubileumsfond (P21-0226)
Örebro University
- License Information
-
More Information
Article History
Received: 6 January 2024
Accepted: 6 September 2024
First Online: 10 September 2024
Competing interests
: Henrik Larsson reports receiving grants from Shire Pharmaceuticals; personal fees from and serving as a speaker for Medice, Shire/Takeda Pharmaceuticals and Evolan Pharma AB; and sponsorship for a conference on attention-deficit/hyperactivity disorder from Shire/Takeda Pharmaceuticals and Evolan Pharma AB, all outside the submitted work. Henrik Larsson is also editor-in-chief of JCPP Advances. All other authors do not hold any competing interest.
